A profile of volatile organic compounds in exhaled air as a potential non-invasive biomarker for liver cirrhosis
Open Access
- 29 January 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 19903
Abstract
Early diagnosis of liver cirrhosis may prevent progression and development of complications. Liver biopsy is the current standard, but is invasive and associated with morbidity. We aimed to identify exhaled volatiles within a heterogeneous group of chronic liver disease (CLD) patients that discriminates those with compensated cirrhosis (CIR) from those without cirrhosis and compare this with serological markers. Breath samples were collected from 87 CLD and 34 CIR patients. Volatiles in exhaled air were measured by gas chromatography mass spectrometry. Discriminant Analysis was performed to identify the optimal panel of serological markers and VOCs for classifying our patients using a random training set of 27 CIR and 27 CLD patients. Two randomly selected independent internal validation sets and permutation test were used to validate the model. 5 serological markers were found to distinguish CIR and CLD patients with a sensitivity of 0.71 and specificity of 0.84. A set of 11 volatiles discriminated CIR from CLD patients with sensitivity of 0.83 and specificity of 0.87. Combining both did not further improve accuracy. A specific exhaled volatile profile can predict the presence of compensated cirrhosis among CLD patients with a higher accuracy than serological markers and can aid in reducing liver biopsies.Keywords
This publication has 45 references indexed in Scilit:
- Rapid “Breath-Print” of Liver Cirrhosis by Proton Transfer Reaction Time-of-Flight Mass Spectrometry. A Pilot Study.PLOS ONE, 2013
- Reproducibility and Respiratory Function Correlates of Exhaled Breath Fingerprint in Chronic Obstructive Pulmonary DiseasePLOS ONE, 2012
- Breath biomarkers of liver cirrhosisJournal of Chromatography B, 2012
- Integrated statistical learning of metabolic ion mobility spectrometry profiles for pulmonary disease identificationGenetics and Molecular Research, 2012
- Performance of the Aspartate Aminotransferase-to-Platelet Ratio Index for the Staging of Hepatitis C-Related Fibrosis: An Updated Meta-Analysis §ΔHepatology, 2010
- Now there are many (stages) where before there was oneHepatology, 2010
- Liver biopsy†Hepatology, 2009
- GC–MS analysis of breath odor compounds in liver patientsJournal of Chromatography B, 2008
- FIB-4Hepatology, 2007
- Sampling Variability of Liver Fibrosis in Chronic Hepatitis CHepatology, 2003